TYLER DIAL: Open Payments
NPI 1689172868 · PEMBROKE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 61 payments from 13 companies in 2025. Trend: 2023 $529 · 2024 $1,007 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $304 |
| GlaxoSmithKline, LLC. | 10 | $203 |
| Paratek Pharmaceuticals, Inc. | 9 | $151 |
| Lilly USA, LLC | 9 | $121 |
| Abbott Laboratories | 3 | $70 |
| PFIZER INC. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Novo Nordisk Inc | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: TRELEGY ELLIPTA, FARXIGA, NUZYRA, MOUNJARO, AIRSUPRA, REXULTI, XIFAXAN, BREZTRI.
Industry payments across NC — which companies pay providers there.
